{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:29Z","timestamp":1790949689714,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-NHLHCRF-YS-02"],"award-info":[{"award-number":["2022-NHLHCRF-YS-02"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232145"],"award-info":[{"award-number":["7232145"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The aim of the study was to investigate the characteristics and prognosis of patients with immune-mediated necrotizing myopathy (IMNM) based on clinical, serological and pathological classification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 138 patients with IMNM who met the 2018 European Neuromuscular Center criteria for IMNM including 62 anti-SRP, 32 anti-HMGCR-positive and 44 myositis-specific antibody\u2013negative were involved in the study. All patients were followed up and evaluated remission and relapse. Clustering analysis based on clinical, serological and pathological parameters was used to define subgroups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Clustering analysis classified IMNM into three clusters. Cluster 1 patients (n\u2009=\u200935) had the highest creatine kinase (CK) levels, the shortest disease course, severe muscle weakness and more inflammation infiltration in muscle biopsy. Cluster 2 patients (n\u2009=\u200979) had the lowest CK level and moderate inflammation infiltrate. Cluster 3 patients (n\u2009=\u200924) had the youngest age of onset, the longest disease course and the least frequency of inflammatory infiltration. Patients in cluster 3 had the longest time-to-remission [median survival time: 61 (18.3, 103.7) vs 20.5 (16.2, 24.9) and 27 (19.6, 34.3) months] and shorter relapse-free time than those in cluster 1 and 2 [median remission time 95% CI 34 (19.9, 48.0) vs 73 (49.0, 68.7) and 73 (48.4, 97.6) months]. Patients with age of onset &amp;gt;55\u2009years, more regeneration of muscle fibres, more CD4+ T infiltration and membrane attack complex deposition had more favourable outcomes regarding time to achieving remission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Stratification combining clinical, serological and pathological features could distinguish phenotypes and prognosis of IMNM. The pathological characteristics may impact the long-term prognosis of patients with IMNM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae361","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T21:56:53Z","timestamp":1721339813000},"page":"2252-2264","source":"Crossref","is-referenced-by-count":7,"title":["Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical\u2013serological\u2013pathological classification"],"prefix":"10.1093","volume":"64","author":[{"given":"Hongxia","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Peking University China-Japan Friendship School of Clinical Medicine , Beijing,","place":["China"]},{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1271-1729","authenticated-orcid":false,"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-3444","authenticated-orcid":false,"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Peking University China-Japan Friendship School of Clinical Medicine , Beijing,","place":["China"]},{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Peking University China-Japan Friendship School of Clinical Medicine , Beijing,","place":["China"]},{"name":"Department of Rheumatology, China-Japan Friendship Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"2025040212103657500_keae361-B1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2025040212103657500_keae361-B2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J. Neuromuscul Dis"},{"key":"2025040212103657500_keae361-B3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2025040212103657500_keae361-B4","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025040212103657500_keae361-B5","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/NXI.0000000000000513","article-title":"Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy","volume":"6","author":"Lim","year":"2019","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"2025040212103657500_keae361-B6","first-page":"87","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Nishino","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2025040212103657500_keae361-B7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"2025040212103657500_keae361-B8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2025040212103657500_keae361-B9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2025040212103657500_keae361-B10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2016.09.005","article-title":"Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories","volume":"15","author":"Alvarado-Cardenas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2025040212103657500_keae361-B11","doi-asserted-by":"crossref","first-page":"e5694","DOI":"10.1097\/MD.0000000000005694","article-title":"Atorvastatin-induced necrotizing autoimmune myositis","volume":"96","author":"Troyanov","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025040212103657500_keae361-B12","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutarylcoenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212103657500_keae361-B13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-018-2589-z","article-title":"Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase","volume":"75","author":"Essers","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"2025040212103657500_keae361-B14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","article-title":"Statin-induced anti-HMGCR myopathy\u202f: successful therapeutic strategies for corticosteroid-free remission in 55 patients","volume":"22","author":"Meyer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025040212103657500_keae361-B15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/rheumatology\/keaa337","article-title":"Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies","volume":"60","author":"Close","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212103657500_keae361-B16","doi-asserted-by":"crossref","first-page":"670784","DOI":"10.3389\/fneur.2021.670784","article-title":"The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front Neurol"},{"key":"2025040212103657500_keae361-B17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg. Psychiatry"},{"key":"2025040212103657500_keae361-B18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jnen\/nly017","article-title":"Revisiting pathological classification criteria for adult idiopathic inflammatory myopathies: in-depth analysis of muscle biopsies and correlation between pathological diagnosis and clinical manifestations","volume":"77","author":"Hou","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025040212103657500_keae361-B19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotising myopathy: a multi-centre South Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2025040212103657500_keae361-B20","doi-asserted-by":"crossref","first-page":"152011","DOI":"10.1016\/j.semarthrit.2022.152011","article-title":"Serum levels of anti-transcriptional intermediary factor 1-\u03b3 autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis","volume":"55","author":"Zhang","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212103657500_keae361-B21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthritis Care Res"},{"key":"2025040212103657500_keae361-B22","first-page":"303","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Publ Gr"},{"key":"2025040212103657500_keae361-B23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025040212103657500_keae361-B24","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya","year":"2016","journal-title":"Neurol Neuroimmunol. NeuroInflammation"},{"key":"2025040212103657500_keae361-B25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy","volume":"72","author":"Alfugham","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025040212103657500_keae361-B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","article-title":"Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort","volume":"29","author":"Hou","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"2025040212103657500_keae361-B27","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"2025040212103657500_keae361-B28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye","year":"2015","journal-title":"Muscle and Nerve"},{"key":"2025040212103657500_keae361-B29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.24642","article-title":"The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy","volume":"52","author":"Chung","year":"2015","journal-title":"Muscle and Nerve"},{"key":"2025040212103657500_keae361-B30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03009742.2019.1672782","article-title":"Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level","volume":"49","author":"Aggarwal","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2025040212103657500_keae361-B31","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1093\/rheumatology\/keac198","article-title":"Statin-associated immune-mediated necrotizing myositis in Native Americans","volume":"61","author":"Muruganandam","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212103657500_keae361-B32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212103657500_keae361-B33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-020-01431-7","article-title":"Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies","volume":"15","author":"Zhao","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2025040212103657500_keae361-B34","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol Neuroimmunol. NeuroInflammation"},{"key":"2025040212103657500_keae361-B35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.160871","article-title":"Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","volume":"44","author":"Tansley","year":"2017","journal-title":"J Rheumatol"},{"key":"2025040212103657500_keae361-B36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212103657500_keae361-B37","first-page":"1","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"2025040212103657500_keae361-B38","doi-asserted-by":"crossref","first-page":"e507\u201317","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP + and anti-HMGCR + myopathies","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"2025040212103657500_keae361-B39","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preu\u00dfe","year":"2012","journal-title":"Am J Pathol"},{"key":"2025040212103657500_keae361-B40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann Neurol"},{"key":"2025040212103657500_keae361-B41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/ars.2017.7420","article-title":"The role of metabolic remodeling in macrophage polarization and its effect on skeletal muscle regeneration","volume":"30","author":"De Santa","year":"2019","journal-title":"Antioxidants Redox Signal"},{"key":"2025040212103657500_keae361-B42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.it.2020.04.006","article-title":"Inflammation and skeletal muscle regeneration: leave it to the macrophages!","volume":"41","author":"Chazaud","year":"2020","journal-title":"Trends Immunol"},{"key":"2025040212103657500_keae361-B43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1249\/JES.0000000000000201","article-title":"Macrophage regulation of muscle regrowth from disuse in aging","volume":"47","author":"Reidy","year":"2019","journal-title":"Exerc Sport Sci Rev"},{"key":"2025040212103657500_keae361-B44","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s10753-016-0438-8","article-title":"Macrophage depletion impairs skeletal muscle regeneration: the roles of pro-fibrotic factors, inflammation, and oxidative stress","volume":"39","author":"Xiao","year":"2016","journal-title":"Inflammation"},{"key":"2025040212103657500_keae361-B45","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41467-017-01526-z","article-title":"Complement C3a signaling facilitates skeletal muscle regeneration by regulating monocyte function and trafficking","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae361\/58789670\/keae361.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2252\/58789670\/keae361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2252\/58789670\/keae361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:44:43Z","timestamp":1743612283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/2252\/7717359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae361","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,7,19]]}}}